Sickle cell disease affects nearly 8 million people worldwide, most in sub-Saharan Africa.
Articles on Sickle cell disorder
Displaying all articles
Research has long shown that patients often experience poor hospital care during sickle cell crises.
Following the controversial births of the first gene-edited babies, a major focus of the Third International Summit on Human Genome Editing was responsible use of CRISPR.
Evolutionary medicine uses our ancestral history to explain disease prevalence and inform care for conditions like Type 2 diabetes. It also challenges the bio-ethnocentrism of western medicine.
Lessons from a study of sickle cell and employment.
Top contributors
-
Professor of Bioinformatics, Rochester Institute of Technology
-
Dean of the College of Science, Professor of Biochemistry, Rochester Institute of Technology
-
Graduate Student - Department of Psychology, Laurentian University
-
Professor of Applied Sociology, De Montfort University
-
Professor, Applied Evolutionary Ecology, Laurentian University
-
Visiting Associate Professor, University of Cambridge
-
Postdoctoral Fellow, Faculty of Health Sciences, McMaster University
-
HARP Doctoral Research Fellow and Haematology Registrar, Queen Mary University of London
-
Learning Disability Nurse, Oxford University Hospitals NHS Foundation Trust & NIHR Pre-Doctoral Clinical Academic Fellow, King's College London
-
Senior Lecturer in Biomedical Sciences, Brunel University of London
-
Senior Lecturer in Biomedical Sciences, Brunel University of London